SATS vs SRPT · rev $15.83B vs rev $1.13B
EchoStar Corporation (SATS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
EchoStar Corporation (SATS) is a telecom services company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SATS revenue for 2024-12-31 was $15.83B. Net income was -$124.5M. Revenue was up 280.2% from 2023-12-31 to 2024-12-31. SATS currently screens at market cap $32.37B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
SATS currently screens at market cap $32.37B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SATS and SRPT stock pages for the full models.
Not investment advice.